Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion Trial
复发/难治性高危神经母细胞瘤患者的Fcγ受体多态性与SIOPEN Dinutuximab Beta长期输注试验的预后相关
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0180
Lode, Holger N; Siebert, Nikolai; Valteau-Couanet, Dominique; Garaventa, Alberto; Canete, Adela; Anderson, John; Yaniv, Isaac; Ash, Shifra; Gray, Juliet; Klingebiel, Thomas; Loibner, Hans; Luksch, Roberto; Manzitti, Carla; Michon, Jean Marie; Owens, Cormac; Pötschger, Ulrike; Troschke-Meurer, Sascha; Glogova, Evgenia; Ladenstein, Ruth